Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Daily News

Andexanet Alfa Pulled From US Market

Todd Neale

December 22, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

L.A. McKeown

June 12, 2024

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

Todd Neale

March 08, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

L.A. McKeown

October 14, 2021

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

L.A. McKeown

August 20, 2021

News Daily News

Skin Cancer Risk With Common Diuretics Confirmed Anew

L.A. McKeown

April 14, 2021

News Daily News

FDA Approves Rilonacept to Treat Recurrent Pericarditis and to Curb Recurrences

Shelley Wood

March 25, 2021

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Daily News

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Yael L. Maxwell

May 16, 2019

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

News Daily News

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

Shelley Wood

February 22, 2019

Advertisement

Andexanet Alfa Pulled From US Market

TCTMD’s Top 10 Most Popular Stories for July 2025

FDA Approves Triple Therapy Polypill for High Blood Pressure

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

FDA Grants MACE Reduction Indication for Semaglutide

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

FDA Issues New Guidance on Sodium Targets for Food Industry

Could an App Replace Statin Prescribing by Doctors?

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

Skin Cancer Risk With Common Diuretics Confirmed Anew

FDA Approves Rilonacept to Treat Recurrent Pericarditis and to Curb Recurrences

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Signal of Aortic Stenosis Risk With Celecoxib

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content